These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37322894)

  • 41. Coverage of Novel Therapeutic Agents by Medicare Prescription Drug Plans Following FDA Approval.
    Shaw DL; Dhruva SS; Ross JS
    J Manag Care Spec Pharm; 2018 Dec; 24(12):1230-1238. PubMed ID: 30479199
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Developing a Standardized and Reusable Method to Link Distributed Health Plan Databases to the National Death Index: Methods Development Study Protocol.
    Fuller CC; Hua W; Leonard CE; Mosholder A; Carnahan R; Dutcher S; King K; Petrone AB; Rosofsky R; Shockro LA; Young J; Min JY; Binswanger I; Boudreau D; Griffin MR; Adgent MA; Kuntz J; McMahill-Walraven C; Pawloski PA; Ball R; Toh S
    JMIR Res Protoc; 2020 Nov; 9(11):e21811. PubMed ID: 33136063
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pragmatic Trials in Maintenance Dialysis: Perspectives from the Kidney Health Initiative.
    Dember LM; Archdeacon P; Krishnan M; Lacson E; Ling SM; Roy-Chaudhury P; Smith KA; Flessner MF
    J Am Soc Nephrol; 2016 Oct; 27(10):2955-2963. PubMed ID: 27401689
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pragmatic (trial) informatics: a perspective from the NIH Health Care Systems Research Collaboratory.
    Richesson RL; Green BB; Laws R; Puro J; Kahn MG; Bauck A; Smerek M; Van Eaton EG; Zozus M; Hammond WE; Stephens KA; Simon GE
    J Am Med Inform Assoc; 2017 Sep; 24(5):996-1001. PubMed ID: 28340241
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of Out-of-Pocket Spending on Ultra-Expensive Drugs in Medicare Part D vs Commercial Insurance.
    DiStefano MJ; Kang SY; Parasrampuria S; Anderson GF
    JAMA Health Forum; 2023 May; 4(5):e231090. PubMed ID: 37234016
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Price-Quality Mismatch: Are Negotiated Prices for Total Joint Arthroplasty Associated With Hospital Quality in a Large California Health System?
    Zhuang T; Shapiro LM; Baker LC; Kamal RN
    Clin Orthop Relat Res; 2023 Jun; 481(6):1061-1068. PubMed ID: 36729581
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enhancing the use of EHR systems for pragmatic embedded research: lessons from the NIH Health Care Systems Research Collaboratory.
    Richesson RL; Marsolo KS; Douthit BJ; Staman K; Ho PM; Dailey D; Boyd AD; McTigue KM; Ezenwa MO; Schlaeger JM; Patil CL; Faurot KR; Tuzzio L; Larson EB; O'Brien EC; Zigler CK; Lakin JR; Pressman AR; Braciszewski JM; Grudzen C; Fiol GD
    J Am Med Inform Assoc; 2021 Nov; 28(12):2626-2640. PubMed ID: 34597383
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Will choice-based reform work for Medicare? Evidence from the Federal Employees Health Benefits Program.
    Florence CS; Atherly A; Thorpe KE
    Health Serv Res; 2006 Oct; 41(5):1741-61. PubMed ID: 16987300
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Selecting Outcomes to Ensure Pragmatic Trials Are Relevant to People Living with Dementia.
    Hanson LC; Bennett AV; Jonsson M; Kelley A; Ritchie C; Saliba D; Teno J; Zimmerman S
    J Am Geriatr Soc; 2020 Jul; 68 Suppl 2(Suppl 2):S55-S61. PubMed ID: 32589279
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of health plan combined with registry data to predict clinical trial recruitment.
    Curtis JR; Wright NC; Xie F; Chen L; Zhang J; Saag KG; Bharat A; Kremer J; Cofield S; Winthrop K; Delzell E
    Clin Trials; 2014 Feb; 11(1):96-101. PubMed ID: 24346611
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Stakeholder views regarding ethical issues in the design and conduct of pragmatic trials: study protocol.
    Nicholls SG; Carroll K; Brehaut J; Weijer C; Hey SP; Goldstein CE; Zwarenstein M; Graham ID; McKenzie JE; McIntyre L; Jairath V; Campbell MK; Grimshaw JM; Fergusson DA; Taljaard M
    BMC Med Ethics; 2018 Nov; 19(1):90. PubMed ID: 30458809
    [TBL] [Abstract][Full Text] [Related]  

  • 52. What types of real-world evidence studies do U.S. commercial health plans cite in their specialty drug coverage decisions?
    Panzer AD; Margaretos NM; Lai RC; Enright DE; Chambers JD
    Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1307-1311. PubMed ID: 32212282
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Medicare program; Medicare prescription drug benefit. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2005 Jan; 70(18):4193-585. PubMed ID: 15678603
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The design and conduct of a pragmatic cluster randomized trial of an advance care planning program for nursing home residents with dementia.
    Hickman SE; Mitchell SL; Hanson LC; Tu W; Stump TE; Unroe KT
    Clin Trials; 2022 Dec; 19(6):623-635. PubMed ID: 35815777
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Methodological challenges in pragmatic trials in Alzheimer's disease and related dementias: Opportunities for improvement.
    Taljaard M; Li F; Qin B; Cui C; Zhang L; Nicholls SG; Carroll K; Mitchell SL
    Clin Trials; 2022 Feb; 19(1):86-96. PubMed ID: 34841910
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ethical Issues in the Design and Conduct of Pragmatic Cluster Randomized Trials in Hemodialysis Care: An Interview Study With Key Stakeholders.
    Nicholls SG; Carroll K; Weijer C; Goldstein CE; Brehaut J; Sood MM; Al-Jaishi A; Basile E; Grimshaw JM; Garg AX; Taljaard M
    Can J Kidney Health Dis; 2020; 7():2054358120964119. PubMed ID: 33194212
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of Patient Migration Patterns and Related Health Care Costs Within a National Medicare Advantage Prescription Drug Plan After Implementation of an Oxycodone HCl Extended-Release Access Restriction.
    Chen CC; De AP; Sweet B; Wade RL
    J Manag Care Spec Pharm; 2017 Aug; 23(8):902-912. PubMed ID: 28737985
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A dynamic application of PRECIS-2 to evaluate implementation in a pragmatic, cluster randomized clinical trial in two nursing home systems.
    Palmer JA; Mor V; Volandes AE; McCreedy E; Loomer L; Carter P; Dvorchak F; Mitchell SL
    Trials; 2018 Aug; 19(1):453. PubMed ID: 30134976
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.